PMC:7118659 / 16841-17013
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T100 | 112-121 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
| T101 | 166-171 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid_AGAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p76567s15 | 81-91 | MPA | denotes | production |
| p76567s25 | 132-142 | PosReg | denotes | activating |
| p76567s26 | 143-171 | MPA | denotes | anti-SARS-CoV-2 CD8+ T-cells |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T102 | 12-20 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T103 | 148-156 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T213 | 132-142 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
| T214 | 159-162 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
| T215 | 164-171 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T-cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T183 | 34-38 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 685 | 159-162 | Gene | denotes | CD8 | Gene:925 |
| 703 | 148-158 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 715 | 12-20 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T96 | 0-172 | Sentence | denotes | Finally, in COVID-19 disease this drug could act indirectly through reducing the production of pro-inflammatory cytokines and/or by activating anti-SARS-CoV-2 CD8+ T-cells. |